28 October 2021

Pharmaceuticals Rheumatoid Arthritis

End of the line for OA drug tanezumab

28 October 2021

Biologics Gout Research

Spare a thought for the sperm

28 October 2021

Conditions PBS

24-hour BP monitoring on MBS from next week

28 October 2021

COVID-19 Spondyloarthritis

No increase in arthritis flares after vaccination: study

28 October 2021

Conditions Research

Can gut bacteria control inflammatory diseases?

21 October 2021

Conditions COVID-19

Remote monitoring keeps patients safe at home

21 October 2021

Conditions

White coat hypertension not fixed by short wait

21 October 2021

osteomyelitis Spondyloarthritis

Faster is not always better with MTX

21 October 2021

Biologics Spondyloarthritis

Another drug shortage – now it’s abatacept

21 October 2021

Ankylosing Spondylitis Biologics Biosimilars Conditions O&G

How to help patients understand their biosimilar options

18 October 2021

Biologics Reactive Arthritis

Rituximab in line for open PBS listing without authority

14 October 2021

Biologics Comment Conditions

Read the September magazine online!

14 October 2021

Conditions

The future of immunotherapy

14 October 2021

Scleroderma

Oral treatments most favoured by PsA patients

13 October 2021

Conditions Imaging Technology

It’s an exciting time to be a spine

7 October 2021

Ankylosing Spondylitis Biologics Corticosteroids COVID-19

No significant link between cancer and bDMARDs